Involvement of the Kinin‐generating Cascade in Enhanced Vascular Permeability in Tumor Tissue

Japanese Journal of Cancer Research

Volumn 79, Issue 12, 1988, Pages 1327-1334

  Matsumura, Yasuhiro ^a   Kimura, Masami ^a   Yamamoto, Tetsuro ^a   Maeda, Hiroshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Bradykinin in tumor ascites; Enhanced extravascular permeability in tumor; Kinin generating cascade; Macromolecular drug delivery; Manipulation of kinin level

Indexed keywords

3 (2 GUANIDINOETHYLTHIO) 2 (MERCAPTOMETHYL)PROPIONIC ACID; BRADYKININ; CAPTOPRIL; ENALAPRIL; RADIOISOTOPE;

ANIMAL EXPERIMENT; ARTICLE; ASCITES TUMOR; BLOOD VESSEL PERMEABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW;

ANIMAL; ASCITES; BRADYKININ; CAPILLARY PERMEABILITY; CAPTOPRIL; KININS; LYSINE CARBOXYPEPTIDASE; NEOPLASMS, EXPERIMENTAL; RATS; SERUM ALBUMIN, BOVINE; SUPPORT, NON-U.S. GOV'T; TRYPSIN INHIBITORS;

EID: 0024151625     PISSN: 09105050     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1988.tb01563.x     Document Type: Article

References (25)

1. Pathogenesis of serratial infection: activation of the Hageman factor‐prekallikrein cascade by serratial protease
2. A serratial protease causes vascular permeability reaction by activation of the Hageman factor‐dependent pathway in guinea pigs
3. Enhancement of vascular permeability upon serratial infection: activation of Hageman factor‐kallikrein‐kinin cascade
4. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
5. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines
6. A lipophilic derivative of neocarzinostatin. A polymer conjugation an antitumor protein antibiotic
7. Conjugation of poly (styrene‐co‐maleic acid) derivatives to the antitumor protein neocarzinostatin: pronounced improvements in pharmacological properties
8. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
9. Cancer selective macromolecular therapeusis: tailoring of an antitumor protein drug
10. Use of oily contrast medium for selective drug targeting to tumor enhanced therapeutic effect and X‐ray image
11. Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report
12. Selective targeting of anticancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium
13. Tumor targeting by arterial administration of lipids: rabbit model with VX2 carcinoma in the liver
14. Medical regression and its functional significance in tumor‐supplying host arteries: a morphometric study of hepatic arteries in human liver with hepatocellular carcinoma
15. Design of specific inhibitors of angiotensin‐converting enzyme: new class of orally active antihypertensive agents
16. Effect of N‐[(s)‐I‐carboxy‐3‐phenylpropyl]L‐Ala‐L‐Pro and its ethyl ester (MK‐421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo
17. A potent mercapto bi‐product analogue inhibitor for human carboxypeptidase N
18. Studies on leukokinins. III. pharmacological activities
19. 3‐bradykinin in ascitic fluid from a patient with gastric cancer
20. The preparation and labeling of DTPA‐coupled albumin
21. Attaching metal ions to antibodies
22. Labeling of monoclonal antibodies with indium 111 technique and advantages compared to radioiodine labeling
23. Activation of plasma kallikrein‐kinin system and its significant role in pleural fluid accumulation of rat carrageenin‐induced pleurisy
24. Inhibition of vascular permeability changes in rats by captopril
25. Pepstatin — an inhibitor of leukokinin formation and ascitic fluid accumulation